Chien-Chung Lin

Prof. Dr. Chien-Chung Lin

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
QLQing Lan
Qing Lan
CHChao A Hsiung
Chao A Hsiung
Keitaro MatsuoKeitaro Matsuo
Keitaro Matsuo
YHYun-Chul Hong
Yun-Chul Hong
ASAdeline Seow
Adeline Seow
NRNathaniel Rothman
Nathaniel Rothman

12 October 2015 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
JSJoshua N. Sampson
Joshua N. Sampson
WWWilliam A. Wheeler
William A. Wheeler
MYMeredith Yeager
Meredith Yeager
OPOrestis Panagiotou
Orestis Panagiotou
ZWZhaoming Wang
Zhaoming Wang
NCNilanjan Chatterjee
Nilanjan Chatterjee
Studies of related individuals have consistently demonstrated notable familial aggregation of cancer. We aim to estimate the heritability and genetic correlation attributable to the additive effects of common single-nucleotide polymorphisms (SNPs) for cancer at 13 anatomical sites. Between 2007 and 2014, the US National Cancer Institute has generated data from genome-wide association studies (GWAS) for 49 492 cancer case patients and 34 131 control patients. We apply novel mixed model methodology (GCTA) to this GWAS data to estimate the heritability of individual cancers, as well as the proportion of heritability attributable to cigarette smoking in smoking-related cancers, and the genetic correlation between pairs of cancers. GWAS heritability was statistically significant at nearly all sites, with the estimates of array-based heritability, hl (2), on the liability threshold (LT) scale ranging from 0.05 to 0.38. Estimating the combined heritability of multiple smoking characteristics, we calculate that at least 24% (95% confidence interval [CI] = 14% to 37%) and 7% (95% CI = 4% to 11%) of the heritability for lung and bladder cancer, respectively, can be attributed to genetic determinants of smoking. Most pairs of cancers studied did not show evidence of strong genetic correlation. We found only four pairs of cancers with marginally statistically significant correlations, specifically kidney and testes (ρ = 0.73, SE = 0.28), diffuse large B-cell lymphoma (DLBCL) and pediatric osteosarcoma (ρ = 0.53, SE = 0.21), DLBCL and chronic lymphocytic leukemia (CLL) (ρ = 0.51, SE =0.18), and bladder and lung (ρ = 0.35, SE = 0.14). Correlation analysis also indicates that the genetic architecture of lung cancer differs between a smoking population of European ancestry and a nonsmoking Asian population, allowing for the possibility that the genetic etiology for the same disease can vary by population and environmental exposures. Our results provide important insights into the genetic architecture of cancers and suggest new avenues for investigation.

1 November 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
FWFang Wei
Fang Wei
CLChien-Chung Lin
Chien-Chung Lin
AJAron Y Joon
Aron Y Joon
ZFZiding Feng
Ziding Feng
GTGabriel Troche
Gabriel Troche
David WongDavid Wong
David Wong
Rationale: Constitutive activation of the epidermal growth factor receptor (EGFR) is prevalent in epithelial cancers, particularly in non-small cell lung carcinoma (NSCLC). Mutations identified in EGFR predict the sensitivity to EGFR-targeted therapy. Detection of these mutations is mainly based on tissue biopsy, which is invasive, expensive, and time consuming. Objectives: Noninvasive, real-time, inexpensive detection and monitoring of EGFR mutations in patients with NSCLC is highly desirable. Methods: We developed a novel core technology, electric field–induced release and measurement (EFIRM), which relies on a multiplexible electrochemical sensor that can detect EGFR mutations directly in bodily fluids. Measurements and Main Results: We established EFIRM for the detection of the EGFR mutations in vitro and correlated the results with tumor size from xenografted mice. In clinical application, we demonstrated that EFIRM could detect EGFR mutations in the saliva and plasma of 22 patients with NSCLC. Finally, a blinded test was performed on saliva samples from 40 patients with NSCLC. The receiver operating characteristic analysis indicated that EFIRM detected the exon 19 deletion with an area under the curve of 0.94 and the L858R mutation with an area under the curve of 0.96. Conclusions: Our data indicate that EFIRM is effective, accurate, rapid, user-friendly, and cost effective for the detection of EGFR mutations in the saliva of patients with NSCLC. We termed this saliva-based EGFR mutation detection (SABER).

5 August 2010 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CHChao Agnes Hsiung
Chao Agnes Hsiung
QLQing Lan
Qing Lan
YHYun-Chul Hong
Yun-Chul Hong
CCChien-Jen Chen
Chien-Jen Chen
HHH. Dean Hosgood
H. Dean Hosgood
DLDongxin Lin
Dongxin Lin
Genome-wide association studies of lung cancer reported in populations of European background have identified three regions on chromosomes 5p15.33, 6p21.33, and 15q25 that have achieved genome-wide significance with p-values of 10−7 or lower. These studies have been performed primarily in cigarette smokers, raising the possibility that the observed associations could be related to tobacco use, lung carcinogenesis, or both. Since most women in Asia do not smoke, we conducted a genome-wide association study of lung adenocarcinoma in never-smoking females (584 cases, 585 controls) among Han Chinese in Taiwan and found that the most significant association was for rs2736100 on chromosome 5p15.33 (p = 1.30×10−11). This finding was independently replicated in seven studies from East Asia totaling 1,164 lung adenocarcinomas and 1,736 controls (p = 5.38×10−11). A pooled analysis achieved genome-wide significance for rs2736100. This SNP marker localizes to the CLPTM1L-TERT locus on chromosome 5p15.33 (p = 2.60×10−20, allelic risk = 1.54, 95% Confidence Interval (CI) 1.41–1.68). Risks for heterozygote and homozygote carriers of the minor allele were 1.62 (95% CI; 1.40–1.87), and 2.35 (95% CI: 1.95–2.83), respectively. In summary, our results show that genetic variation in the CLPTM1L-TERT locus of chromosome 5p15.33 is directly associated with the risk of lung cancer, most notably adenocarcinoma. Worldwide, approximately 15% of lung cancer cases occur among nonsmokers. Genome-wide association studies (GWAS) of lung cancer conducted in populations of European background have identified three regions on chromosomes 5, 6, and 15 that harbor genetic variants that confer risk for lung cancer. Prior studies were conducted primarily in cigarette smokers, raising the possibility that the associations could be related to tobacco use, lung carcinogenesis, or both. A GWAS of lung cancer among never-smokers is an optimal setting to discover effects that are independent of smoking. Since most women in Asia do not smoke, we conducted a GWAS of lung adenocarcinoma among never-smoking females (584 cases, 585 controls) in Taiwan, and observed a region on chromosome 5 significantly associated with risk for lung cancer in never-smoking women. The finding was independently replicated in seven studies from East Asia totaling 1,164 lung adenocarcinomas and 1,736 controls. To our knowledge, this study is the first reported GWAS of lung cancer in East Asian women, and together with the replication studies represents the largest genetic association study in this population. The findings provide insight into the genetic contribution of common variants to lung carcinogenesis.

10 December 2015 in Periodontology 2000
Verified
Journal Article
Closed access
PDF file
YZYong Zhang
Yong Zhang
JSJie Sun
Jie Sun
CLChien-Chung Lin
Chien-Chung Lin
EAElliot Abemayor
Elliot Abemayor
MWMarilene B. Wang
Marilene B. Wang
DWDavid T. W. Wong
David T. W. Wong

1 January 2011 in Lung Cancer
Verified
Journal Article
Closed access
WSWen-Pin Su
Wen-Pin Su
YCYen-Ting Chen
Yen-Ting Chen
WLWu-Wei Lai
Wu-Wei Lai
CLChien-Chung Lin
Chien-Chung Lin
JYJing-Jou Yan
Jing-Jou Yan
Wu-Chou  SuWu-Chou Su
Wu-Chou Su